Carasent ASA
OSE:CARA
P/E
Price to Earnings
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
Market Cap | P/E | ||||
---|---|---|---|---|---|
NO |
C
|
Carasent ASA
OSE:CARA
|
1.4B NOK | -24.3 | |
US |
Veeva Systems Inc
NYSE:VEEV
|
29.9B USD | 53.8 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 47.3 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | -116.8 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
13.1B AUD | 188.6 | ||
JP |
M3 Inc
TSE:2413
|
1.1T JPY | 23.3 | ||
US |
Doximity Inc
NYSE:DOCS
|
5.5B USD | 37.4 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
4.8B USD | -303.5 | ||
SE |
Sectra AB
STO:SECT B
|
47.9B SEK | 111.8 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
3.3B USD | -507.9 | ||
US |
Vocera Communications Inc
NYSE:VCRA
|
2.8B USD | -324 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.